| Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y002# (NCT05266768) | Chunrui Li | 2022-04-28 |
| A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants (NCT05796479) | Sanofi | 2022-04-28 |
| CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia (NCT05727683) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2022-04-28 |
| A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma (NCT05243342) | Genentech, Inc. | 2022-04-28 |
| Regorafenib in Patients With Refractory Primary Bone Tumors (NCT05395741) | Institute of Mother and Child, Warsaw, Poland | 2022-04-28 |
| A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years. (NCT05354089) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-04-27 |
| Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y001# (NCT05270928) | The First Affiliated Hospital of Soochow University | 2022-04-27 |
| Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently (NCT05257447) | University of Texas Southwestern Medical Center | 2022-04-27 |
| Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors (NCT05198505) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-04-27 |
| A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906 (NCT05296733) | Boehringer Ingelheim | 2022-04-27 |
| Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007) (NCT05136690) | Merck Sharp & Dohme LLC | 2022-04-27 |
| A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants (NCT05355935) | Insmed Incorporated | 2022-04-27 |
| A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA (NCT05237752) | LG Chem | 2022-04-27 |
| Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis (NCT05159050) | Carlos Chan | 2022-04-26 |
| Phase I Clinical Trial of BH002 in Patients With Advanced Solid Tumors (NCT06231277) | Zhuhai Beihai Biotech Co., Ltd | 2022-04-26 |
| First in Human Study of T3P-Y058-739 (T3P) (NCT05120596) | T3 Pharmaceuticals AG | 2022-04-26 |
| Controlled Human Infection Model Challenge/Rechallenge (NCT04992520) | PATH | 2022-04-26 |
| Minimally Invasive Esophagectomy Pain Control Trial (NCT05906134) | Swedish Medical Center | 2022-04-26 |
| To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19. (NCT05351437) | Memo Therapeutics AG | 2022-04-26 |
| Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport (NCT05334108) | Emalex Biosciences Inc. | 2022-04-26 |
| A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101 (NCT05238493) | Veloxis Pharmaceuticals | 2022-04-26 |
| Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (NCT05184764) | Armata Pharmaceuticals, Inc. | 2022-04-26 |
| First in Human Study to Compare Safety Between Intravenous Bolus Versus Infusion of ApTOLL (NCT05569720) | aptaTargets S.L. | 2022-04-25 |
| Lutathera and ASTX727 in Neuroendocrine Tumours (NCT05178693) | Imperial College London | 2022-04-25 |
| Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects (NCT05368935) | Genfit | 2022-04-25 |
| An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia (NCT05226468) | New Epsilon Innovation Limited | 2022-04-25 |
| Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy (NCT05678881) | Receptor Life Sciences | 2022-04-25 |
| Feasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space (NCT05369221) | Peking Union Medical College Hospital | 2022-04-25 |
| Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma With Ociperlimab (BGB-A1217) in Combination With Tislelizumab (BGB-A317) or Rituximab (NCT05267054) | BeiGene | 2022-04-25 |
| The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock (NCT05402553) | Noha Mansour | 2022-04-24 |
| Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers (NCT05191862) | Genovate Biotechnology Co., Ltd., | 2022-04-23 |
| Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model (NCT05366439) | Atea Pharmaceuticals, Inc. | 2022-04-22 |
| Lefamulin for M. Genitalium Treatment Failures (NCT05111002) | University of Washington | 2022-04-22 |
| Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors (NCT05169944) | University of California, San Francisco | 2022-04-22 |
| Socially Assistive Robots to Enhance Magnification Device Use for Reading (NCT04190134) | University of California, Los Angeles | 2022-04-22 |
| A New Study Evaluating the Activity of Modular CAR T for mYeloma (NCT04795882) | University College, London | 2022-04-22 |
| Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations (NCT05300048) | Faeth Therapeutics | 2022-04-22 |
| MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors (NCT05076760) | Memgen, Inc. | 2022-04-21 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses (NCT05310032) | Glaceum | 2022-04-21 |
| Safety and Tolerability of FMT Capsules in Healthy Volunteers (NCT05352269) | Shenzhen Xbiome Biotech Co., Ltd. | 2022-04-21 |
| A Study of SGN-ALPV in Advanced Solid Tumors (NCT05229900) | Seagen Inc. | 2022-04-21 |
| A Study of CM350 in Patients With Advanced Solid Tumors (NCT05263960) | Keymed Biosciences Co.Ltd | 2022-04-21 |
| Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer (NCT04791384) | Criterium, Inc. | 2022-04-21 |
| Novel in Vivo Synaptic Imaging in Experienced Meditators (NCT05418608) | Yale University | 2022-04-21 |
| A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers (NCT05215912) | TeneoFour Inc. | 2022-04-21 |
| A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions (NCT04964050) | GlaxoSmithKline | 2022-04-21 |
| First-in-Human Study of TAK-280 in Participants With Solid Tumors (NCT05220098) | Takeda | 2022-04-21 |
| PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets (NCT04920292) | Swiss Tropical & Public Health Institute | 2022-04-21 |
| First in Human, Single Ascending Dose Study (NCT05844592) | Innovo Therapeutics, Inc. | 2022-04-21 |
| A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions (NCT05347576) | Chong Kun Dang Pharmaceutical | 2022-04-21 |
| A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy Participants (NCT05304533) | Bristol-Myers Squibb | 2022-04-21 |
| ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine (NCT05656508) | Laboratorio Pablo Cassara S.R.L. | 2022-04-20 |
| FMT for Postop Crohn's Disease (NCT05248191) | University of Minnesota | 2022-04-20 |
| Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer (NCT05251766) | Xuli Meng | 2022-04-20 |
| Co-transplantation of Mesenchymal Stem Cell Derived Exosomes and Autologous Mitochondria for Patients Candidate for CABG Surgery (NCT05669144) | Tehran University of Medical Sciences | 2022-04-20 |
| FLIGHT Study for Childhood Chronic Illness (NCT06377384) | Documenting Hope Project | 2022-04-20 |
| Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression (NCT03522545) | The University of Texas Health Science Center, Houston | 2022-04-20 |
| A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes. (NCT05363774) | Novo Nordisk A/S | 2022-04-20 |
| Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors (NCT05352750) | Sonnet BioTherapeutics | 2022-04-20 |
| CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer (NCT05029999) | University of Texas Southwestern Medical Center | 2022-04-20 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| A Study of HFB301001 in Adult Patients With Advanced Solid Tumors (NCT05229601) | HiFiBiO Therapeutics | 2022-04-20 |
| Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667 (NCT05335447) | Lakefront Biotherapeutics NV | 2022-04-19 |
| Base Edited CAR7 T Cells to Treat T Cell Malignancies (TvT CAR7) (NCT05397184) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2022-04-19 |
| Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers (NCT05460065) | NEURALIS s.a. | 2022-04-19 |
| Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC (NCT05085496) | City of Hope Medical Center | 2022-04-19 |
| Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NCT05363761) | Neurotronic, Inc. | 2022-04-19 |
| A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage (NCT05427682) | Sunshine Lake Pharma Co., Ltd. | 2022-04-19 |
| Clinical Study of BR105 Injection (NCT05351697) | BioRay Pharmaceutical Co., Ltd. | 2022-04-19 |
| A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors (NCT05293496) | MacroGenics | 2022-04-19 |
| Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System (NCT05211336) | National Cancer Institute (NCI) | 2022-04-19 |
| A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study) (NCT04945018) | Heartseed Inc. | 2022-04-19 |
| A Study of WJ05129 in Advanced Malignant Solid Tumors (NCT05326035) | Suzhou Junjing BioSciences Co., Ltd. | 2022-04-19 |
| PreOperative Brain Irradiation in Glioblastoma (NCT03582514) | The Christie NHS Foundation Trust | 2022-04-19 |
| A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection (NCT05242445) | Janssen Research & Development, LLC | 2022-04-19 |
| A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participants (NCT05324124) | Loxo Oncology, Inc. | 2022-04-19 |
| Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors (NCT05223231) | Nanjing Leads Biolabs Co.,Ltd | 2022-04-19 |
| Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD (NCT04910152) | Hannah Choe, MD | 2022-04-19 |
| Boost Study 31380 (mHealth) (NCT05757453) | NXTech | 2022-04-18 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (PEG)-BHD1028 (NCT06563115) | EncuraGen, Inc | 2022-04-18 |
| The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study (NCT04726241) | PedAL BCU, LLC | 2022-04-18 |
| A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001) (NCT05231746) | STCube, Inc. | 2022-04-18 |
| Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer (NCT05232409) | Valley Health System | 2022-04-17 |
| A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19 (NCT06039163) | Huahui Health | 2022-04-16 |
| Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics (NCT05323136) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2022-04-15 |
| The Effect of Intra Operative Dexmedetomidine in Prevention of Early Postoperative Atrial Fibrillation (NCT05320705) | Kasr El Aini Hospital | 2022-04-15 |
| Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers (NCT04260776) | Fred Hutchinson Cancer Center | 2022-04-15 |
| Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions (NCT05339373) | Pharmtechnology LLC | 2022-04-15 |
| 64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression (NCT04605614) | City of Hope Medical Center | 2022-04-15 |
| A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants (NCT05320094) | Bristol-Myers Squibb | 2022-04-15 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy Subjects (NCT05328583) | RetroLead (Shanghai) BioPharma Co., Ltd. | 2022-04-15 |
| Intralesional HPV Vaccine for Condylomata (NCT05087849) | University of California, San Francisco | 2022-04-15 |
| Study for the Prevention of Oral Mucositis (SPOM) (NCT05338398) | E2Bio Life Sciences, LLC | 2022-04-15 |
| Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury (NCT05524103) | AlaMab Therapeutics (Shanghai) Inc. | 2022-04-15 |
| Cardioprotective Effect of Ketamine-dexmeditomidine Versus Fentanyl-midazolam in Open Heart Surgery in Pediatrics (NCT05314569) | Cairo University | 2022-04-15 |
| A Food-Effect Study of BPI-16350 in Healthy Subjects (NCT05316259) | Betta Pharmaceuticals Co., Ltd. | 2022-04-15 |
| HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas (NCT05180695) | Centre Leon Berard | 2022-04-15 |
| A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers (NCT05192395) | Daewoong Pharmaceutical Co. LTD. | 2022-04-15 |
| A Gene Therapy Study in Patients With Gaucher Disease Type 1 (NCT05324943) | Spur Therapeutics | 2022-04-15 |
| Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology (NCT05184569) | Peter Ljubenkov, MD | 2022-04-14 |